MedTech Spectrum

Article Name Medtech

How Early Stage Detection of Cancer Significantly Improves Cancer Survival Rates

In the session on Cancer screening, the experts emphasised that early detection of cancer, as well as cancer screenings at intervals, play a great role in decreasing deaths related to cancer

24th November, 2025

AIROS Medical Launches Custom Travel Case for Lymphedema Compression Therapy Devices

The case will allow patients to safely and conveniently transport their AIROS compression therapy devices

21st November, 2025

VEITH Symposium Showcases Emerging AI Applications in Vascular Care

The session highlighted the growing importance of AI-enabled imaging, simulation, and digital workflow tools within vascular surgery and interventional practice

21st November, 2025

AI is Transforming the Future of Pathology as Pictor Labs Leads the Shift to Virtual Staining

MedTech Spectrum speaks with Pictor Labs leaders to explore how ClearStain is reshaping histology and sequencing, preserving precious tissue, improving turnaround times, and strengthening the foundations of precision oncology.

18th November, 2025

1 Out of 10 Facing Risk of Diabetes: Suraksha Doctor Shares Five Tips to Control Diabetes

Diabetes is one of the main causes of kidney failure, heart attack, stroke, lower limb amputation, and blindness

14th November, 2025

New analysis highlights urgent need to increase adaptation finance for health

Only 0.5% of multilateral climate finance goes to health, despite climate change projected to cause up to 15.6 millions deaths by 2050.

11th November, 2025

World Immunization Day: Why Adult Immunization Matters

Adult immunisation matters since it protects adults from potentially serious vaccine-preventable diseases, reduces the spread of infections to vulnerable populations through herd immunity

11th November, 2025

Inside Olympus’ Vision for the Next Era of Endoscopy-Enabled Care

The global MedTech leader has unveiled a sweeping strategy to redefine endoscopy-enabled care, a move that positions the company at the heart of the industry’s shift toward intelligent, integrated, and minimally invasive medicine

11th November, 2025

TAICEND's Patented Fish Collagen Technology Brings Breakthrough in the Healing of Hard-to-Heal Wounds

The formulation preserves the triple-helix structure of fish collagen, creating a stable biological scaffold that enhances cellular support throughout the healing process

10th November, 2025

BioProtect Reports 4-Year Follow-Up Results Showing Lasting Quality-of-Life Gains

The newly presented data from the 164-patient cohort, confirm that these anatomic and dosimetric advantages translate into clinically meaningful, sustained preservation of quality of life

10th November, 2025

Olympus Unveils Corporate Strategy

Shaping the future of endoscopy-enabled care through innovation and operational excellence

07th November, 2025

Outset Medical Unveils Landmark Data on Dialysis Innovation at ASN Kidney Week 2025

Data from over 1 million Tablo treatments among the findings presented at the American Society of Nephrology’s Kidney Week 2025

06th November, 2025

Femasys Secures FDA Approval to Advance Final FemBloc Trial Phase and $12Mn Financing

Successful completion of the first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval

04th November, 2025

Apollo Cradle & Fertility unveils 3rd National Cradle Conference 2025

Apollo Cradle & Children’ Hospital along with Apollo Fertility launches the 3rd National Cradle Conference 2025, highlighting breakthrough technologies and best practices in fertility, maternal and child health

03rd November, 2025

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data

03rd November, 2025

Strengthening Global Collaboration to Build Resilient, Sustainable Vaccine Ecosystem

The forum discusses strategies to strengthen vaccine production capacity, accelerate technology transfer, and expand access to safe, high-quality, and affordable vaccines for all

03rd November, 2025

HighTide’s HTD1801 Shows Long-Term Benefits for Type 2 Diabetes in Phase III Studies

The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM

31st October, 2025